HIV continues to be a major health concern with approximately 2.1 million new infections occurring worldwide in 2015. In Central America, Guatemala had the highest incident number of HIV infections (3,700) in 2015. Antiretroviral pre-exposure prophylaxis (PrEP) was recently recommended by the World Health Organization (WHO) as an efficacious intervention to prevent HIV transmission. PrEP implementation efforts are underway in Guatemala and success will require providers that are knowledgeable and willing to prescribe PrEP. We sought to explore current PrEP awareness and prescribing attitudes among Guatemalan physicians in order to inform future PrEP implementation efforts.We conducted a cross-sectional survey of adult internal medicine phys...
HIV Pre-exposure Prophylaxis (PrEP), in which HIV-negative individuals receive antiretroviral medica...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Antiretroviral treatment for HIV-infection before immunologic decline (early ART) and pre-exposure c...
HIV continues to be a major health concern with approximately 2.1 million new infections occurring w...
INTRODUCTION:HIV continues to be a major health concern with approximately 2.1 million new infection...
Recent evidence has demonstrated the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention,...
<div><p>Recent evidence has demonstrated the efficacy of pre-exposure prophylaxis (PrEP) for HIV pre...
Recent evidence has demonstrated the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention,...
OBJECTIVES:As trials were assessing the safety and efficacy of daily oral antiretroviral preexposure...
Pre-exposure prophylaxis (PrEP) is the provision of antiretroviral drugs before HIV exposure to prev...
Background: HIV leads to a high proportion of infectious disease morbidity and mortality among men w...
Worldwide HIV rates have slowly been decreasing, except among men who have sex with men, where unfor...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
Pre-exposure prophylaxis (PrEP) implementation is underway across sub-Saharan Africa. However, littl...
There are too many new HIV infections globally with 1.8 million persons infected in 2016 alone. Pre-...
HIV Pre-exposure Prophylaxis (PrEP), in which HIV-negative individuals receive antiretroviral medica...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Antiretroviral treatment for HIV-infection before immunologic decline (early ART) and pre-exposure c...
HIV continues to be a major health concern with approximately 2.1 million new infections occurring w...
INTRODUCTION:HIV continues to be a major health concern with approximately 2.1 million new infection...
Recent evidence has demonstrated the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention,...
<div><p>Recent evidence has demonstrated the efficacy of pre-exposure prophylaxis (PrEP) for HIV pre...
Recent evidence has demonstrated the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention,...
OBJECTIVES:As trials were assessing the safety and efficacy of daily oral antiretroviral preexposure...
Pre-exposure prophylaxis (PrEP) is the provision of antiretroviral drugs before HIV exposure to prev...
Background: HIV leads to a high proportion of infectious disease morbidity and mortality among men w...
Worldwide HIV rates have slowly been decreasing, except among men who have sex with men, where unfor...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
Pre-exposure prophylaxis (PrEP) implementation is underway across sub-Saharan Africa. However, littl...
There are too many new HIV infections globally with 1.8 million persons infected in 2016 alone. Pre-...
HIV Pre-exposure Prophylaxis (PrEP), in which HIV-negative individuals receive antiretroviral medica...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Antiretroviral treatment for HIV-infection before immunologic decline (early ART) and pre-exposure c...